StockData
Filana Therapeutics, Inc. logo

Filana Therapeutics, Inc. (FLNA) stock

FLNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$0.64+0.08 (+14.52%)

Close on Nov 20, 2026Market cap $30.98MP/E –Yield –

Filana Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Filana Therapeutics's total assets was $103.90M at Jun 30, 2026. For fiscal 2025 it was $118.36M, down 24.9% from the year before. Over ten years it grew 14.0% a year on average. The highest annual figure on record is $266.78M in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$118.36M-24.9%
FY2024Dec 31, 2024$157.53M+3.9%
FY2023Dec 31, 2023$151.66M-35.4%
FY2022Dec 31, 2022$234.83M-12.0%
FY2021Dec 31, 2021$266.78M+182.9%
FY2020Dec 31, 2020$94.30M+301.5%
FY2019Dec 31, 2019$23.49M+16.6%
FY2018Dec 31, 2018$20.14M+85.9%
FY2017Dec 31, 2017$10.83M-43.9%
FY2016Dec 31, 2016$19.30M-39.5%
FY2015Dec 31, 2015$31.92M-22.0%
FY2014Dec 31, 2014$40.91M-18.4%
FY2013Dec 31, 2013$50.10M-11.9%
FY2012Dec 31, 2012$56.86M-42.5%
FY2011Dec 31, 2011$98.96M-0.2%
FY2010Dec 31, 2010$99.20M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$103.90M-23.3%
Q1 FY2026Mar 31, 2026$108.37M-23.1%
Q4 FY2025Dec 31, 2025$118.36M-24.9%
Q3 FY2025Sep 30, 2025$129.73M-42.0%
Q2 FY2025Jun 30, 2025$135.38M-44.4%
Q1 FY2025Mar 31, 2025$140.93M-9.5%
Q4 FY2024Dec 31, 2024$157.53M+3.9%
Q3 FY2024Sep 30, 2024$223.75M+29.7%
Q2 FY2024Jun 30, 2024$243.57M+23.5%
Q1 FY2024Mar 31, 2024$155.72M-28.6%
Q4 FY2023Dec 31, 2023$151.66M-35.4%
Q3 FY2023Sep 30, 2023$172.53M-16.8%
Q2 FY2023Jun 30, 2023$197.25M-13.3%
Q1 FY2023Mar 31, 2023$218.11M-10.7%
Q4 FY2022Dec 31, 2022$234.83M-12.0%
Q3 FY2022Sep 30, 2022$207.29M-24.4%
Q2 FY2022Jun 30, 2022$227.38M-19.2%
Q1 FY2022Mar 31, 2022$244.19M-14.0%
Q4 FY2021Dec 31, 2021$266.78M+182.9%
Q3 FY2021Sep 30, 2021$274.25M+979.8%
Q2 FY2021Jun 30, 2021$281.31M+1003.2%
Q1 FY2021Mar 31, 2021$284.05M+993.5%
Q4 FY2020Dec 31, 2020$94.30M+301.5%
Q3 FY2020Sep 30, 2020$25.40M+38.2%
Q2 FY2020Jun 30, 2020$25.50M+35.6%
Q1 FY2020Mar 31, 2020$25.98M+33.1%
Q4 FY2019Dec 31, 2019$23.49M+16.6%
Q3 FY2019Sep 30, 2019$18.38M-11.8%
Q2 FY2019Jun 30, 2019$18.81M+91.2%
Q1 FY2019Mar 31, 2019$19.52M+76.6%
Q4 FY2018Dec 31, 2018$20.14M+85.9%
Q3 FY2018Sep 30, 2018$20.84M+68.3%
Q2 FY2018Jun 30, 2018$9.83M-31.1%
Q1 FY2018Mar 31, 2018$11.06M-37.2%
Q4 FY2017Dec 31, 2017$10.83M-43.9%
Q3 FY2017Sep 30, 2017$12.38M-44.9%
Q2 FY2017Jun 30, 2017$14.27M–
Q1 FY2017Mar 31, 2017$17.60M–
Q4 FY2016Dec 31, 2016$19.30M–
Q3 FY2016Sep 30, 2016$22.48M–

More Filana Therapeutics figures

See a number that looks wrong?